Assessment and Plan
This patient requires urgent cross-sectional imaging (CT abdomen/pelvis with IV contrast) to evaluate for pseudomyxoma peritonei or recurrent/residual low-grade appendiceal mucinous neoplasm (LAMN), followed by immediate surgical oncology consultation.
Clinical Context
This 49-year-old woman presents with persistent RLQ pain 7 months post-appendectomy that revealed acute suppurative appendicitis with atypical glands and inspissated mucin suspicious for LAMN. The pathology report explicitly recommended immunohistochemistry studies (ER, PR, PAX8, CDX2) for confirmation, but there's no documentation these were completed. Her current presentation with severe RLQ pain (10/10), tachycardia (HR 110), and diarrhea raises concern for:
- Incomplete initial resection - LAMN may have extended beyond the appendix
- Pseudomyxoma peritonei (PMP) - dissemination of mucin and neoplastic cells into the peritoneum
- Residual disease requiring definitive oncologic management
Immediate Diagnostic Workup
Priority Imaging
- CT abdomen/pelvis with IV contrast to assess for:
- Peritoneal implants or mucinous ascites (PMP)
- Residual appendiceal tissue or cecal involvement
- Fluid collections or abscess formation
- Lymphadenopathy (though rare in LAMN)
Laboratory Studies
- Complete blood count (already showing tachycardia, assess for leukocytosis)
- Comprehensive metabolic panel
- Tumor markers: CEA, CA 19-9, CA-125 (baseline for LAMN surveillance)
Critical Missing Information
- Confirm the immunohistochemistry results from the original pathology specimen
- Review original operative report for margin status and extent of resection
- Obtain original pathology slides for re-review by surgical pathology
Risk Stratification for LAMN
Based on recent evidence 1, key risk factors for PMP development include:
- T stage (T4a and especially T4b disease)
- Appendiceal perforation (3 of 12 patients with perforation developed PMP)
- Acellular mucin on serosa (4 of 18 patients developed recurrence)
- Positive surgical margins
The original pathology described "periappendicitis" and "inspissated mucin," which suggests at minimum T3 disease (extension through muscularis propria) and possibly T4a (perforation with acellular mucin on serosa).
Definitive Management Algorithm
If Imaging Shows No Peritoneal Disease:
For Tis (LAMN confined to mucosa) or T3 with negative margins:
- Appendectomy alone is sufficient 1
- Colonoscopy to evaluate appendiceal orifice and exclude synchronous lesions 2
- Surveillance imaging every 6-12 months for 2-5 years
For T4a (acellular mucin on serosa) without risk factors:
- Right hemicolectomy may be sufficient 1
- However, recent case reports 3 demonstrate discontinuous mucin infiltration into cecal wall not detected preoperatively
- Given this patient's "suspicious" pathology and lack of confirmed immunohistochemistry, right hemicolectomy is strongly recommended
If Imaging Shows Peritoneal Disease (PMP):
For T4b disease or confirmed PMP:
- Cytoreductive surgery (CRS) + hyperthermic intraperitoneal chemotherapy (HIPEC) is the definitive treatment 1
- This combination showed superior outcomes in patients with established risk factors
- Mean survival: 93.3 months without recurrence vs. 32 months with recurrence (p=0.021) 1
Urgent Consultations Required
- Surgical Oncology - for definitive surgical planning
- Medical Oncology - if peritoneal disease confirmed
- Gastroenterology - for colonoscopy once acute symptoms resolve
Current Symptom Management
Her acute presentation with RLQ pain and diarrhea may represent:
- Inflammatory response from residual disease
- Partial obstruction from adhesions or tumor
- Infectious complication (though less likely given lack of fever)
Immediate management:
- NPO status until imaging completed
- IV hydration for tachycardia and diarrhea
- Pain control (avoid masking peritoneal signs)
- Broad-spectrum antibiotics if imaging suggests infection/abscess 4
Critical Pitfalls to Avoid
- Do not assume simple appendectomy was adequate - The pathology explicitly stated "suspicious for LAMN" and recommended confirmatory studies
- Do not delay imaging - PMP has significantly worse prognosis if diagnosis is delayed
- Do not perform colonoscopy before cross-sectional imaging - Need to rule out peritoneal disease first
- Do not dismiss persistent symptoms - Recurrence occurred in 4 patients in one series, all with T4 disease 1
Prognosis Considerations
- Small G1 neuroendocrine tumors (<2 cm) have excellent prognosis with appendectomy alone 5, 6
- LAMN without perforation or mucin spillage has favorable outcomes with appropriate resection 1, 7
- PMP development significantly worsens prognosis and requires aggressive CRS/HIPEC 1
The key determinant is whether this represents incomplete initial treatment of LAMN versus development of PMP - imaging and surgical oncology evaluation cannot be delayed.